The stock of Colgate-Palmolive Company (NYSE:CL) decreased by -$0.17 on Tuesday to finish at $73.47, down -0.23 percent. The last five days have seen an average of 3,081,820 shares of common stock traded. 7 times new highs were reached in the current year, with a fall of -$5.32. The average number of shares traded over the last 20 days was 3,462,190, while the average volume over the last 50 days totaled 4,559,024.
CL stock dropped -3.66% since last month. On 08/29/23, the company’s shares reached a one-month low of $72.45. The stock touched a high of $82.09 on 05/15/23, after rallying from a low of $67.84 in 52 weeks. The price of CL stock has declined by -6.75% or -$5.32 this year, reaching a new high 7 times. Still, the stock price is down -10.50% from the 52-week high.
Insider Transactions
CL stock investors should be aware that Colgate-Palmolive Company (CL) stock had its last reported insider trading activity 28 days ago on Aug 02. On Aug 02, Chief of Staff Kooyman John W sold 21,677 shares at $77.69 each. This transaction resulted in the insider making $1,684,062. On May 19, Daniels Jennifer sold 24,703 shares at a price of US$79.70. After the transaction, the insider now owns 52,769 shares. Chief Human Resources Officer Massey Sally had earlier sold 14,594 shares on May 15 for $81.55 a share. The transaction was completed for $1,190,141.
Valuation Metrics
Colgate-Palmolive Company (CL) has a trailing price-to-earnings (P/E) ratio of 40.98. Beta for the stock is 0.49. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 3.23, and the price-to-cash flow ratio of 25.60.
Company paid $0.48 per share in dividends, remained unchanged from $0.48 last year. A $0.01 dividend increase was reported on Thursday March 9 2023.
Financial Health
For the three months ended June 30, Colgate-Palmolive Company’s quick ratio was 0.70, while its current ratio was 1.20, indicating its inability to pay off its debt. As far as profitability goes, gross margin for the trailing twelve months is 56.90% percent. Colgate-Palmolive Company’s EBITDA margin for the year ended June 30 was 22.99%, whereas its operating margin stood at 14.80% for the same period. Based on annual data, it had gross profit of $10.25 billion and revenue of $17.97 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. CL’s return on assets (ROA) during the last 12 months has been 9.30%. There was a 23.80% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 628.30%.
Earnings Surprise
According to Colgate-Palmolive Company’s quarterly financial report for the quarter that ended June 30. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $4.82 billion, while revenues rose by 7.01% to $4.77 billion. It was predicted that Colgate-Palmolive Company’s quarterly earnings would be $0.77, but it ended up being $0.75, beating the consensus by 2.70%. EBITDA was $1.12 billion for the quarter. At the end of Colgate-Palmolive Company’s most recent quarter ended June 30, its liabilities totaled 15.91 billion, while its total debt was $8.99 billion. Equity owned by shareholders amounts to $826.69 million.
Technical Picture
Here’s a quick look at Colgate-Palmolive Company’s (CL) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 34.03%, suggesting the stock is Neutral, with a 8.34% historical volatility rate.
The stochastic %K and %D were 17.13% and 13.02% respectively, while the average true range (ATR) was 1.02. Based on the 14-day stochastic reading of 21.54%, the RSI (14) reading is 36.88%. On the 9-day MACD Oscillator, the stock is at -0.09, and the 14-day reading is at -0.75.
Analyst Ratings
In its analyst report released on February 17, 2023, Citigroup began covering Colgate-Palmolive Company (NYSE: CL). The stock was rated as a Buy by the brokerage firm. Analysts have assigned Colgate-Palmolive Company (CL) an Overweight rating. CL is a stock that is recommended for selling by 0 brokerage firms, while 12 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 9 others recommend it as a buy.
What is CL’s price target for the next 12 months?
The current consensus forecast for the stock is between $68.00 and $98.00, with a median target price of $85.00. In analyzing these forecasts, the average price target given by analysts for Colgate-Palmolive Company (CL) is $85.40.
